Skip to main content

Table 2 Sensitivity and specificity of the ctDNA methylation test and CEA in patients with tumor load

From: Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer

Biopsy finding

ctDNA methylation test (n = 804)*

n

Positive results (n)

Negative results (n)

Sensitivity %

Specificity %

Stage I

7

6

1

85.7

 

Stage II

43

32

11

74.4

 

Stage III

125

104

21

83.2

 

Stage IV

227

197

30

86.8

 

Total

402

339

63

84.3

 

Normal controls

402

22

380

 

94.5

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us